The protein encoded by this gene is a member of the TNF receptor (TNFR) associated factor (TRAF) protein family. TRAF proteins associate with, and mediate the signal transduction from various receptors of the TNFR superfamily. This protein and TRAF2 form a heterodimeric complex, which is required for TNF-alpha-mediated activation of MAPK8/JNK and NF-kappaB. The protein complex formed by this protein and TRAF2 also interacts with inhibitor-of-apoptosis proteins (IAPs), and thus mediates the anti-apoptotic signals from TNF receptors. The expression of this protein can be induced by Epstein-Barr virus (EBV). EBV infection membrane protein 1 (LMP1) is found to interact with this and other TRAF proteins; this interaction is thought to link LMP1-mediated B lymphocyte transformation to the signal transduction from TNFR family receptors.
^Rothe M, Wong SC, Henzel WJ, Goeddel DV (September 1994). "A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor". Cell78 (4): 681–92. doi:10.1016/0092-8674(94)90532-0. PMID8069916.
^Shu HB, Halpin DR, Goeddel DV (June 1997). "Casper is a FADD- and caspase-related inducer of apoptosis". Immunity6 (6): 751–63. PMID9208847.
^Kataoka T, Budd RC, Holler N, Thome M, Martinon F, Irmler M et al. (June 2000). "The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways". Curr. Biol.10 (11): 640–8. PMID10837247.
^Micheau O, Tschopp J (July 2003). "Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes". Cell114 (2): 181–90. PMID12887920.
^Leo E, Deveraux QL, Buchholtz C, Welsh K, Matsuzawa S, Stennicke HR et al. (March 2001). "TRAF1 is a substrate of caspases activated during tumor necrosis factor receptor-alpha-induced apoptosis". J. Biol. Chem.276 (11): 8087–93. doi:10.1074/jbc.M009450200. PMID11098060.
^Oukka M, Kim ST, Lugo G, Sun J, Wu LC, Glimcher LH (January 2002). "A mammalian homolog of Drosophila schnurri, KRC, regulates TNF receptor-driven responses and interacts with TRAF2". Mol. Cell9 (1): 121–31. PMID11804591.
^Galibert L, Tometsko ME, Anderson DM, Cosman D, Dougall WC (Dec 1998). "The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily". J. Biol. Chem.273 (51): 34120–7. PMID9852070.
^Kim HH, Lee DE, Shin JN, Lee YS, Jeon YM, Chung CH et al. (January 1999). "Receptor activator of NF-kappaB recruits multiple TRAF family adaptors and activates c-Jun N-terminal kinase". FEBS Lett.443 (3): 297–302. PMID10025951.
^Bouwmeester T, Bauch A, Ruffner H, Angrand PO, Bergamini G, Croughton K et al. (February 2004). "A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway". Nat. Cell Biol.6 (2): 97–105. doi:10.1038/ncb1086. PMID14743216.
^Takeuchi M, Rothe M, Goeddel DV (August 1996). "Anatomy of TRAF2. Distinct domains for nuclear factor-kappaB activation and association with tumor necrosis factor signaling proteins". J. Biol. Chem.271 (33): 19935–42. PMID8702708.
Hu HM, O'Rourke K, Boguski MS, Dixit VM (1994). "A novel RING finger protein interacts with the cytoplasmic domain of CD40.". J. Biol. Chem.269 (48): 30069–72. PMID7527023.
Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kieff E (1995). "The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family.". Cell80 (3): 389–99. doi:10.1016/0092-8674(95)90489-1. PMID7859281.
Hsu H, Shu HB, Pan MG, Goeddel DV (1996). "TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways.". Cell84 (2): 299–308. doi:10.1016/S0092-8674(00)80984-8. PMID8565075.
Hsu H, Huang J, Shu HB, Baichwal V, Goeddel DV (1996). "TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex.". Immunity4 (4): 387–96. doi:10.1016/S1074-7613(00)80252-6. PMID8612133.
Gedrich RW, Gilfillan MC, Duckett CS, Van Dongen JL, Thompson CB (1996). "CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins.". J. Biol. Chem.271 (22): 12852–8. doi:10.1074/jbc.271.22.12852. PMID8662842.
Takeuchi M, Rothe M, Goeddel DV (1996). "Anatomy of TRAF2. Distinct domains for nuclear factor-kappaB activation and association with tumor necrosis factor signaling proteins.". J. Biol. Chem.271 (33): 19935–42. doi:10.1074/jbc.271.33.19935. PMID8702708.
Marsters SA, Ayres TM, Skubatch M, Gray CL, Rothe M, Ashkenazi A (1997). "Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kappaB and AP-1.". J. Biol. Chem.272 (22): 14029–32. doi:10.1074/jbc.272.22.14029. PMID9162022.
Boucher LM, Marengère LE, Lu Y, Thukral S, Mak TW (1997). "Binding sites of cytoplasmic effectors TRAF1, 2, and 3 on CD30 and other members of the TNF receptor superfamily.". Biochem. Biophys. Res. Commun.233 (3): 592–600. doi:10.1006/bbrc.1997.6509. PMID9168896.
Siemienski K, Peters N, Scheurich P, Wajant H (1997). "Organization of the human tumour necrosis factor receptor-associated factor 1 (TRAF1) gene and mapping to chromosome 9q33-34.". Gene195 (1): 35–9. doi:10.1016/S0378-1119(97)00147-9. PMID9300817.